Douglas Quinn Overview
- Company
- Videregen
- Primary Position
-
Chief Financial...
- Primary Industry
-
Materials and Resources
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Douglas Quinn General Information
Biography
Mr. Douglas Quinn serves as Chief Financial Officer and Board Member at Videregen. He also serves as a Partner at DSW Ventures. He serves as a Board Observer at 4D Biomaterials. He served as Chief Financial Officer at SkinBioTherapeutics. He is an experienced finance director having spent the last 15 years working with early-stage technology businesses. Together with his knowledge and experience of financial management and corporate governance, he has considerable corporate transaction experience having been involved in several M&A transactions, including a medtech AIM float. Alongside Videregen, he is involved in several businesses as a part-time CFO.
Contact Information
Address
- Nexus
- Discovery Way University of Leeds
- Leeds LS2 3AA
- England, United Kingdom
Douglas Quinn Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
DSW Ventures | Investor | Partner | Manchester, United Kingdom | Venture Capital | |
Videregen | Company | Chief Financial Officer & Board Member | Leeds, United Kingdom | Biotechnology |
Douglas Quinn Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
4D Medicine | Other Materials | Privately Held (backing) | Venture Capital-Backed | Nottingham, United Kingdom | |
Videregen | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Leeds, United Kingdom |
Douglas Quinn Lead Partner on Deals (1)
Douglas Quinn has been the lead partner on 1 deal. Their latest deal was with 4D Medicine, a other materials company. The deal was made for on 04-May-2024.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
4D Medicine | 04-May-2024 | Later Stage VC (Series A) | Completed | Other Materials | Nottingham, United Kingdom |
Douglas Quinn Network (19)
Board Members (14)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Philip Smith | 4D Medicine | 4D Medicine | Nottingham, United Kingdom | |
Tom Buckland | 4D Medicine | Self | Nottingham, United Kingdom | |
Videregen | Self | Leeds, United Kingdom | ||
4D Medicine | Self | Nottingham, United Kingdom | ||
Videregen | Self | Leeds, United Kingdom |
Portfolio Executives (5)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Tim O'Connell | 4D Medicine | Chief Financial Officer | 04-May-2024 | Nottingham, United Kingdom |
Andrew Dove Ph.D | 4D Medicine | Co-Founder & Chief Scientific Officer | 04-May-2024 | Nottingham, United Kingdom |
4D Medicine | Chief Executive Officer & Board Member | 04-May-2024 | Nottingham, United Kingdom | |
4D Medicine | Chief Operating Officer | 04-May-2024 | Nottingham, United Kingdom | |
4D Medicine | 3D Printing Business Strategist, Consultant & Board Member | 04-May-2024 | Nottingham, United Kingdom |
Douglas Quinn FAQs
-
Who is Douglas Quinn?
Mr. Douglas Quinn serves as Chief Financial Officer and Board Member at Videregen.
-
How much does Douglas Quinn typically invest?
Douglas Quinn's median deal size is
. -
What is Douglas Quinn’s main position?
Douglas Quinn’s primary position is Chief Financial Officer & Board Member.
-
What are the contact details for Douglas Quinn?
Douglas Quinn’s email address is do
and his phone number is +44 0161 . -
How many active board seats does Douglas Quinn hold?
Douglas Quinn holds 2 board seats including 4D Medicine and Videregen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »